PopVax Launches RNA Foundry for Personalised Cancer Vaccines
Hyderabad biotech PopVax has launched the RNA Foundry with Stochastic Sciences to design and manufacture personalised mRNA cancer vaccines, with capacity for more than 100 patient-specific vaccines in the next 12 months.
